Jee-Fu Huang Selected Research

rice nuclear protein GT-2 (GT-2)

4/2021

Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C patients with genotype-2 infection after completed treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jee-Fu Huang Research Topics

Disease

96	Chronic Hepatitis C 09/2022 - 07/2004
67	Infections 08/2022 - 01/2006
40	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 01/2006
37	Fibrosis (Cirrhosis) 07/2022 - 01/2007
22	Chronic Hepatitis B 01/2022 - 12/2006
20	Neoplasms (Cancer) 02/2022 - 02/2002
19	Hepatitis B 07/2022 - 07/2010
18	Hepatitis C 01/2022 - 07/2008
18	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021 - 01/2006
9	Hepatitis 07/2022 - 06/2007
9	Viremia 02/2021 - 06/2007
8	Liver Diseases (Liver Disease) 10/2021 - 01/2007
7	Non-alcoholic Fatty Liver Disease 03/2022 - 05/2013
6	Fatty Liver 10/2021 - 05/2013
6	Insulin Resistance 05/2015 - 04/2009
5	Body Weight (Weight, Body) 07/2022 - 05/2015
4	Chronic Renal Insufficiency 01/2022 - 04/2021
3	Virus Diseases (Viral Diseases) 02/2022 - 03/2010
3	Hypertension (High Blood Pressure) 01/2022 - 01/2020
3	Coinfection 10/2021 - 01/2006
3	Disease Progression 01/2021 - 06/2017
3	HIV Infections (HIV Infection) 10/2016 - 01/2014
3	Type 2 Diabetes Mellitus (MODY) 05/2015 - 02/2008
2	Glucose Intolerance 09/2022 - 05/2013
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2021
2	Diabetes Mellitus 01/2022 - 07/2016
2	Cryoglobulinemia 01/2022 - 11/2018
2	Chronic Kidney Failure (Chronic Renal Failure) 08/2021 - 01/2021
2	Hyperuricemia 03/2020 - 01/2018
2	End Stage Liver Disease 12/2007 - 12/2006
1	Pneumonia (Pneumonitis) 09/2022
1	COVID-19 09/2022
1	Body Weight Changes 07/2022

Drug/Important Bio-Agent (IBA)

49	Antiviral Agents (Antivirals)IBA 09/2022 - 08/2009
42	Ribavirin (Virazole)FDA LinkGeneric 01/2022 - 01/2006
30	InterferonsIBA 01/2022 - 01/2006
28	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2006
16	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2021 - 06/2007
11	Alanine Transaminase (SGPT)IBA 11/2021 - 01/2006
10	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 02/2008
9	Proteins (Proteins, Gene)FDA Link 03/2022 - 05/2011
9	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2007
7	Biomarkers (Surrogate Marker)IBA 04/2022 - 08/2010
6	Interferon-alpha (Interferon Alfa)IBA 04/2021 - 07/2004
6	Lamivudine (Epivir)FDA Link 11/2016 - 12/2006
5	Hepatitis B e AntigensIBA 07/2022 - 12/2007
5	Sorafenib (BAY 43-9006)FDA Link 02/2022 - 10/2019
5	nasIBA 01/2022 - 01/2019
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022 - 02/2015
5	Triglycerides (Triacylglycerol)IBA 01/2021 - 08/2007
5	Uric Acid (Urate)IBA 03/2020 - 09/2008
5	micaIBA 01/2019 - 12/2015
4	Pharmaceutical PreparationsIBA 02/2022 - 01/2014
4	CytokinesIBA 01/2022 - 03/2011
4	NucleosidesIBA 01/2022 - 11/2020
4	NucleotidesIBA 01/2022 - 11/2020
4	LipidsIBA 11/2020 - 07/2008
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2022 - 01/2011
3	Carrier Proteins (Binding Protein)IBA 03/2022 - 08/2017
3	wisteria lectinIBA 03/2022 - 08/2017
3	SofosbuvirIBA 02/2022 - 01/2021
3	BilirubinIBA 01/2022 - 10/2019
3	Insulin (Novolin)FDA Link 10/2021 - 05/2013
3	AntigensIBA 04/2021 - 11/2016
3	daclatasvirIBA 01/2021 - 02/2019
3	asunaprevirIBA 01/2021 - 02/2019
3	IronIBA 02/2019 - 01/2006
3	Fetal Proteins (Fetoprotein)IBA 03/2018 - 03/2015
3	Phospholipases (Phospholipase)IBA 03/2016 - 03/2015
3	peginterferon alfa-2a (Pegasys)FDA Link 10/2015 - 07/2010
2	Ferritins (Ferritin)IBA 09/2022 - 02/2019
2	TransferasesIBA 01/2022 - 07/2014
2	C-Reactive ProteinIBA 11/2021 - 08/2010
2	AlbuminsIBA 04/2021 - 12/2020
2	Long Noncoding RNAIBA 01/2021 - 05/2020
2	Indicators and Reagents (Reagents)IBA 01/2021 - 02/2019
2	InterleukinsIBA 03/2018 - 04/2013
2	Beclin-1IBA 01/2018 - 11/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2017 - 01/2006
2	Lymphotoxin-alpha (Lymphotoxin)IBA 09/2017 - 07/2017
2	Peptides (Polypeptides)IBA 05/2017 - 12/2015
2	MicroRNAs (MicroRNA)IBA 03/2016 - 05/2014
2	CholesterolIBA 05/2015 - 07/2008
2	Surface Antigens (Surface Antigen)IBA 04/2014 - 06/2007
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2022
1	sofosbuvir drug combination ledipasvirIBA 08/2022
1	tenofovir alafenamideIBA 07/2022
1	Tenofovir (Viread)FDA Link 07/2022
1	CollagenIBA 07/2022
1	EnzymesIBA 02/2022
1	velpatasvirIBA 02/2022
1	ChemokinesIBA 01/2022
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022

Therapy/Procedure

70	Therapeutics 08/2022 - 07/2004
4	Renal Dialysis (Hemodialysis) 08/2021 - 01/2014
3	Liver Transplantation 06/2018 - 01/2007
2	Drug Therapy (Chemotherapy) 02/2022 - 12/2020
2	Aftercare (After-Treatment) 03/2020 - 07/2010
2	Secondary Prevention 06/2017 - 12/2015
1	Artificial Respiration (Mechanical Ventilation) 09/2022